A Phase 1, Healthy Volunteer Qualification Of Ligand [11C] PF-04767135 And Randomized Determination Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET
Latest Information Update: 06 Nov 2021
At a glance
- Drugs PF 4455242 (Primary)
- Indications Bipolar depression
- Focus Pharmacokinetics
- Sponsors Pfizer
- 27 Nov 2014 New trial record